Genetic variation in human serum albumin: A 313 Lys → Asn mutation in albumin reading identified by PCR analysis

Clinica Chimica Acta

Volumn 270, Issue 2, 1998, Pages 195-201

  Savva, Demetris ^a   Li, Bing ^a   Kragh Hansen, Ulrich ^b   Galliano, Monica ^c   Minchiotti, Lorenzo ^c   Tárnoky, András L ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Albumin Reading; Albumin variants; Bisalbuminaemia; PCR for mutant albumin gene

Indexed keywords

ALBUMIN;

AGED; ARTICLE; CASE REPORT; CHEEK; CONTROLLED STUDY; DNA DETERMINATION; ELECTROPHORESIS; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NORMAL HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN VARIANT; SEQUENCE ANALYSIS; TECHNIQUE;

AGED; AMINO ACID SEQUENCE; ASPARAGINE; CYANOGEN BROMIDE; DNA; FEMALE; HUMANS; LYSINE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POINT MUTATION; POLYMERASE CHAIN REACTION; SERUM ALBUMIN; TRYPSIN;

EID: 0032559538     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00208-8     Document Type: Article

References (16)

1. [1] Tárnoky AL. Genetic and drug-induced variation in serum albumin. Adv Clin Chem 1980;21:101-45.
2. [2] Peters T, Jr. All about albumin: biochemistry, genetics and medical applications. San Diego: Academic Press, 1996:170-87.
3. [3] Tárnoky AL, Lestas AN. A new type of bisalbuminaemia. Clin Chim Acta 1964;9:551-8.
4. [4] Melartin L. Albumin polymorphism in man. Acta Pathol et Microbiol Scand 1967;suppl 191.
5. [5] Takahashi N, Takahashi Y, Ishioka N, Blumberg BS, Putnam FW. Application of an automated tandem high-performance liquid chromatographic system to peptide mapping of genetic variants of human serum albumin. J Chromatogr 1986;359:181-91.
6. [6] Galliano M, Minchiotti L, Iadarola P, Stoppini M, Ferri G, Castellani AA. The molecular defect of albumin Tagliacozzo: 313 Lys → Asn. FEBS Lett 1986;208:364-8.
7. [7] Savva D, Tárnoky AL, Vickers MF. Genetic characterization of an alloalbumin, albumin Kashmir, using gene amplification and allele-specific oligonucleotides. Biochem J 1990;266:615-7.
8. [8] Savva D, Mandelstam J. Cloning of the Bacillus subtilis spoIIA and spoVA loci in phage ø0105DI:it. J Gen Microbiol 1984;130:2137-45.
9. [9] Galliano M, Minchiotti L, Iadarola P, Porta F. Screening of CNBr peptides from genetic variants of human serum albumin by isoelectric focusing. In: Peeters H, editor. Protides of biological fluids. Oxford: Pergamon Press, 1986;34:815-8.
10. [10] Minchiotti L, Galliano M, Stoppini M, Ferri G, Crespeau H, Rochu D, Porta F. Two alloalbumins with identical electrophoretic mobility are produced by differently charged amino acid substitutions. Biochim Biophys Acta 1992;1119:232-8.
11. [11] Petersen CE, Scottolini AG, Cody LR, Mandel M et al. A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia. J Med Genet 1994;31:355-9.
12. [12] Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S. An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Comm 1994;202:781-7.
13. 2+ to natural mutants of human serum albumin and proalbumin. Biochem J 1994;301:217-23.
14. [14] Kragh-Hansen U, Minchiotti L, Brennan SO, Sugita O. Hormone binding to natural mutants of human serum albumin. Eur J Biochem 1990;193:169-74.
15. [15] Vestberg K, Galliano M, Minchiotti L, Kragh-Hansen U. High-affinity binding of warfarin, salicylate and diazepam to natural mutants of human serum albumin modified in the C-terminal end. Biochem Pharmacol 1992;44:1515-21.
16. [16] Cotellessa M, Mazzella M, Bruno C, Buzzanca C et al. N1303K mutation and Diabetes mellitus in cystic fibrosis. Arch Dis Child 1996;75:546.